These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 3018032

  • 1. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB, Shulman D, Root AW, Spiliotis BE.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [Abstract] [Full Text] [Related]

  • 3. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
    Jorgensen EV, Schwartz ID, Hvizdala E, Barbosa J, Phuphanich S, Shulman DI, Root AW, Estrada J, Hu CS, Bercu BB.
    J Pediatr Endocrinol; 1993 Sep; 6(2):131-42. PubMed ID: 8102303
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH.
    Chalew SA, Armour KM, Levin PA, Thorner MO, Kowarski AA.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1110-5. PubMed ID: 3084533
    [Abstract] [Full Text] [Related]

  • 5. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of growth hormone secretion: provocative testing vs endogenous 24-hour growth hormone profile.
    Shulman DI, Bercu BB.
    Acta Paediatr Scand Suppl; 1987 Sep; 337():61-71. PubMed ID: 3124498
    [Abstract] [Full Text] [Related]

  • 7. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP, Corder R, Pralong FP, Gaillard RC.
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [Abstract] [Full Text] [Related]

  • 8. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
    Aimaretti G, Baffoni C, Bellone S, Di Vito L, Corneli G, Arvat E, Benso L, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
    [Abstract] [Full Text] [Related]

  • 9. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J, Arce V, Lois N, Tresguerres JA, Lima L.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [Abstract] [Full Text] [Related]

  • 10. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta.
    Marini JC, Bordenick S, Heavner G, Rose S, Hintz R, Rosenfeld R, Chrousos GP.
    J Clin Endocrinol Metab; 1993 Jan; 76(1):251-6. PubMed ID: 8421094
    [Abstract] [Full Text] [Related]

  • 11. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 12. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
    Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F, Ghigo E.
    J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
    [Abstract] [Full Text] [Related]

  • 13. Somatostatin infusion withdrawal: studies in normal children and in children with growth hormone deficiency.
    Cappa M, Rigamonti AE, Bizzarri C, Porzio O, Civolani P, Cella SG, Loche S, Müller EE.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4426-30. PubMed ID: 10599697
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

  • 15. Variable plasma growth hormone (GH)-releasing hormone and GH responses to clonidine, L-dopa, and insulin in normal men.
    Tapanainen P, Knip M, Lautala P, Leppäluoto J.
    J Clin Endocrinol Metab; 1988 Oct; 67(4):845-9. PubMed ID: 3138280
    [Abstract] [Full Text] [Related]

  • 16. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
    Gasperi M, Aimaretti G, Scarcello G, Corneli G, Cosci C, Arvat E, Martino E, Ghigo E.
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
    [Abstract] [Full Text] [Related]

  • 17. Combined growth hormone-releasing hormone and growth hormone-releasing peptide-6 test for the evaluation of growth hormone secretion in children with growth hormone deficiency and growth hormone neurosecretory dysfunction.
    Spiliotis BE, Papadimitriou DT, Alexandrides TK, Karystianos C, Nikiforidis G, Vassilakos P, Beratis NG, Casanueva FF.
    Horm Res; 2008 Aug; 70(4):215-23. PubMed ID: 18772594
    [Abstract] [Full Text] [Related]

  • 18. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 19. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC, Ross JL, Malozowski S, Pescovitz OH, Skerda M, Cassorla F, Loriaux DL, Merriam GR.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [Abstract] [Full Text] [Related]

  • 20. Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction.
    Aimaretti G, Bellone S, Bellone J, Chiabotto P, Baffoni C, Corneli G, Origlia C, de Sanctis C, Camanni F, Ghigo E.
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):287-93. PubMed ID: 10718826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.